Glycopyrrolate is an anticholinergic medication primarily used to treat peptic ulcers and severe drooling in children with specific neurological disorders. By inhibiting acetylcholine, it reduces gastric acid secretion and saliva production, thereby alleviating symptoms associated with these conditions. Its therapeutic role is significant in improving patient comfort and quality of life. In summary, Glycopyrrolate effectively manages peptic ulcers and excessive drooling.
Glycopyrrolate blocks muscarinic receptors, leading to decreased secretion of gastric acid and saliva.















